J. M. Fromson

637 total citations
22 papers, 534 citations indexed

About

J. M. Fromson is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, J. M. Fromson has authored 22 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in J. M. Fromson's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J. M. Fromson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J. M. Fromson collaborates with scholars based in United Kingdom, United States and Ireland. J. M. Fromson's co-authors include Stuart Pearson, James Winfred Bridges, H. Paul A. Illing, C. MacDonald, Ian D. Wilson, John McEwen, Joseph P. Chamberlain, Jason D. Coombes, D. Dell and D. S. Sharp and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Pharmacology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J. M. Fromson

21 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. M. Fromson United Kingdom	11	231	163	136	102	79	22	534
Hugh K. Adam United Kingdom	12	260 1.1×	122 0.7×	89 0.7×	151 1.5×	111 1.4×	14	473
H J Smith United Kingdom	17	283 1.2×	132 0.8×	162 1.2×	314 3.1×	42 0.5×	69	815
William DeMaio United States	12	65 0.3×	81 0.5×	89 0.7×	198 1.9×	47 0.6×	20	493
Schroeder M. Noble United States	9	164 0.7×	226 1.4×	27 0.2×	202 2.0×	107 1.4×	15	507
Denise G. Teotico United States	7	181 0.8×	297 1.8×	35 0.3×	215 2.1×	159 2.0×	8	560
Lawrence J. Marnett United States	8	166 0.7×	67 0.4×	378 2.8×	281 2.8×	37 0.5×	11	801
Ben J. van der Walt South Africa	14	24 0.1×	94 0.6×	66 0.5×	150 1.5×	53 0.7×	25	564
John R. Strauss United States	12	34 0.1×	206 1.3×	84 0.6×	175 1.7×	286 3.6×	18	686
Barbara Malewicz United States	17	58 0.3×	27 0.2×	54 0.4×	456 4.5×	55 0.7×	29	789
Keith Huie United States	13	22 0.1×	91 0.6×	88 0.6×	165 1.6×	61 0.8×	32	547

Countries citing papers authored by J. M. Fromson

Since Specialization

Citations

This map shows the geographic impact of J. M. Fromson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Fromson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Fromson more than expected).

Fields of papers citing papers by J. M. Fromson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Fromson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Fromson. The network helps show where J. M. Fromson may publish in the future.

Co-authorship network of co-authors of J. M. Fromson

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Fromson. A scholar is included among the top collaborators of J. M. Fromson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Fromson. J. M. Fromson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fromson, J. M.. (1989). A phased approach to drug development. Journal of Pharmacokinetics and Biopharmaceutics. 17(4). 509–521. 4 indexed citations

Wilson, Ian D., et al.. (1987). Proton magnetic resonance spectroscopy of human urine: Excretion of 1-(3′-carboxypropyl)-3,7-dimethylxanthine by man after dosing with oxpentifylline. Journal of Pharmaceutical and Biomedical Analysis. 5(2). 157–163. 21 indexed citations

Wilson, Ian D., J. M. Fromson, H. Paul A. Illing, & E Schraven. (1987). The metabolism of [¹⁴C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man. Xenobiotica. 17(1). 93–104. 11 indexed citations

Wilson, Ian D., et al.. (1986). The metabolism of [¹⁴C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in laboratory animals. Xenobiotica. 16(12). 1117–1128. 9 indexed citations

Wilson, Ian D., et al.. (1985). Species differences in the metabolism of 14C-p-trifluoromethylaniline: Production of an oxanilic acid as the major metabolite by the rat. Biochemical Pharmacology. 34(11). 2025–2028. 13 indexed citations

Illing, H. Paul A., et al.. (1983). Disposition of¹⁴C-loprazolam in animals and man. Xenobiotica. 13(7). 439–449. 7 indexed citations

Fromson, J. M., et al.. (1982). The metabolism of 7-ethoxycoumarin and 7-hydroxycoumarin by rat and hairless mouse skin strips. Biochemical Pharmacology. 31(24). 4005–4009. 10 indexed citations

Bridges, James Winfred, et al.. (1982). UDP-Glucuronosyltransferase activity in rat- and hairless mouse skin-microsomes. Xenobiotica. 12(8). 481–487. 11 indexed citations

Fromson, J. M., H. Paul A. Illing, R. M. J. Ings, et al.. (1981). Absorption and disposition of [14C]-molsidomine in laboratory animals.. PubMed. 31(2). 337–45. 7 indexed citations

10.

Fromson, J. M., et al.. (1981). The Drug Metabolism Discussion Group. Xenobiotica. 11(12). 801–801. 1 indexed citations

11.

Fromson, J. M., et al.. (1981). The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man.. Drug Metabolism and Disposition. 9(2). 161–167. 2 indexed citations

12.

Chamberlain, Joseph P., Jason D. Coombes, D. Dell, et al.. (1980). Metabolism of cefotaxime in animals and man. Journal of Antimicrobial Chemotherapy. 6(suppl A). 69–78. 67 indexed citations

13.

Rising, Trevor J., J. M. Fromson, & P. Johnson. (1978). Further absorption studies with the anti-diarrhoeal agent ethacridine lactate in the dog.. PubMed. 28(4). 631–5. 2 indexed citations

14.

Illing, H. Paul A. & J. M. Fromson. (1978). Species differences in the disposition and metabolism of 6,11-dihydro-11-oxodibenz[be]oxepin-2-acetic acid (isoxepac) in rat, rabbit, dog, rhesus monkey, and man.. Drug Metabolism and Disposition. 6(5). 510–517. 8 indexed citations

15.

Rising, Trevor J., J. M. Fromson, John McEwen, & P. Johnson. (1977). Absorption studies with the anti-diarrhoeal agent ethacridine lactate in laboratory animals and man.. PubMed. 27(4). 872–8. 1 indexed citations

16.

Kutney, James P., et al.. (1975). Total Synthesis of Indole and Dihydroindole Alkaloids. VI. The total synthesis of some monomeric vinca alkaloids: dl‐Vincadine, dl‐vincaminoreine, dl‐vincaminorine, dl‐vincadifformine, dl‐minovine and dl‐vincaminoridine. Helvetica Chimica Acta. 58(6). 1648–1671. 22 indexed citations

17.

Fromson, J. M. & D. S. Sharp. (1974). THE SELECTIVE UPTAKE OF TAMOXIFEN BY HUMAN UTERINE TISSUE. BJOG An International Journal of Obstetrics & Gynaecology. 81(4). 321–323. 16 indexed citations

18.

Fromson, J. M., et al.. (1973). The Metabolism of Tamoxifen (I.C.I. 46,474) Part I : In Laboratory Animals. Xenobiotica. 3(11). 693–709. 157 indexed citations

19.

Fromson, J. M., et al.. (1973). The Metabolism of Tamoxifen (I.C.I. 46,474) Part II: In Female Patients. Xenobiotica. 3(11). 711–714. 114 indexed citations

20.

Kutney, James P., et al.. (1968). Total synthesis of some monomeric Vinca alkaloids: dl-vincadine, dl-vincaminoreine, dl-vincaminorine, dl-vincadifformine, dl-minovine, and dl-vincaminoridine. Journal of the American Chemical Society. 90(14). 3891–3893. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact